Skip to main content
OpenTrials
Completed

NCT Number: NCT03833856

Incidence and Clinical Course of Colonoscopy Related Perforation

This study aims to investigate the incidence and clinical course of colonoscopy related perforation based on the result of a prospective registry.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Kyungpook National University Hospital

Daegu, 41944, South Korea

About this study

In each endoscopy unit from participating hospital, there is a alarm system focusing on the development of perforation. Therefore, perforation cases will not be missed from the registry.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who have a perforation after colonoscopy

Exclusion criteria

  • Patients who refuse to be registered.

Treatment and study plan

colonoscopy perforation

Procedure

The development of perforation after colonoscopy

Primary outcomes

  1. Operation

    Time frame: 1 month

    Number of participants who take surgical treatment after perforation

Sponsors and collaborators

Lead sponsor

Kyungpook National University Hospital

Other

Registry information

Official study title

Incidence and Risk of Poor Outcomes After Colonoscopy Related Perforation: Result From a Prospective Data Registry

Important dates

Study start
2017
Primary completion
2020
Study completion
2021
First posted
Feb 7, 2019
Registry last updated
Jan 12, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.